849
D. I. S. P. Resende et al.
Letter
Synlett
(8) Black, D. S.; Edwards, G. L.; Evans, R. H.; Keller, P. A.; Laaman, S.
M. Tetrahedron 2000, 56, 1889.
(9) Liang, Y.; Dong, D.; Lu, Y.; Wang, Y.; Pan, W.; Chai, Y.; Liu, Q.
Synthesis 2006, 3301.
(10) Kawai, H.; Kitayama, T.; Tokunaga, E.; Matsumoto, T.; Sato, H.;
Shiro, M.; Shibata, N. Chem. Commun. 2012, 48, 4067.
(11) Lee, M.; Lee, Y.-J.; Park, E.; Park, Y.; Ha, M. W.; Hong, S.; Lee, Y.-
J.; Kim, T.-S.; Kim, M.-h.; Park, H.-g. Org. Biomol. Chem. 2013, 11,
2039.
(12) Oliva, C. G.; Silva, A. M. S.; Paz, F. A. A.; Cavaleiro, J. A. S. Synlett
2010, 1123.
(13) Oliva, C. G.; Silva, A. M. S.; Resende, D. I. S. P.; Paz, F. A. A.;
Cavaleiro, J. A. S. Eur. J. Org. Chem. 2010, 3449.
(14) Silva, E. M. P.; Silva, A. M. S.; Cavaleiro, J. A. S. Synlett 2011, 2740.
(15) A mixture of iron powder (30 g) and 10% HCl (25 mL) was
stirred vigorously for 1 min. The solution was then filtered off
and the iron powder was washed successively with distilled
water (5 × 25 mL) and absolute EtOH (5 × 25 mL).
Figure 1 Molecular structure of 4d (a) and 4e (b). Thermal ellipsoids
are shown at the 50% probability level, hydrogen atoms are shown with
an arbitrary radius (0.30 Å). C, grey; N, blue; Cl, green; F, yellow; H,
white
(16) Synthesis of 4a–h; General Procedure: To a solution of (R,E)-
1,5-diaryl-3-(nitromethyl)-5-pent-4-en-1-ones 3a–h (0.31
mmol) in a mixture of THF–MeOH (2:1, 6 mL) was successively
added at r.t., AcOH (4.98 mmol) and activated iron powder (14.0
mmol). The resulting mixture was heated at 65 °C for 15 h
under a nitrogen atmosphere. After cooling to r.t., the reaction
mixture was filtered through Celite and rinsed with EtOAc. The
resultant solution was washed with sat. aq NaHCO3, brine, dried
over Na2SO4, filtered and concentrated under reduced pressure.
The resulting residue was purified by column chromatography
(hexane–EtOAc, 80:20). Finally the residues were crystallized
from hexane–EtOAc to furnish the desired compounds 4a–h.
Compound 4a: Yield: 72%; brown oil. 1H NMR (300 MHz,
CDCl3): δ = 7.85 (dd, J = 7.0, 2.3 Hz, 2 H, H-2′,6′), 7.45–7.19 (m,
8 H, H-3′,5′, H-4′, H-2′′,6′′, H-3′′,5′′, H-4′′), 6.47 (d, J = 15.8 Hz,
1 H, H-β), 6.24 (dd, J = 15.8, 7.9 Hz, 1 H, H-α), 4.33 (dd, J = 15.6,
7.2 Hz, 2 H, H-5), 3.90 (dd, J = 15.6, 5.1 Hz, 1 H, H-5), 3.36–3.19
(m, 2 H, H-3, H-4), 2.97–2.81 (m, 1 H, H-3). 13C NMR (75 MHz,
CDCl3): δ = 172.7 (C-2), 137.1 (C-1′′), 134.2 (C-1′), 132.2 (C-α),
130.5 (C-4′), 129.9 (C-β), 128.5 (C-3′,5′,C-3′′,5′′), 127.5 (C-2′,6′),
127.2 (C-4′′), 126.0 (C-2′′,6′′), 67.2 (C-5), 41.8 (C-3), 41.3 (C-4).
HRMS (ESI+): m/z [C18H17N + H]+ calcd for C19H17N: 248.1434;
found: 248.1433. HPLC (i-PrOH–hexane, 10:90; flow rate 0.7
mL/min; λ = 254 nm): tr = 10.90 [(R)-4a] min (ee = 99%).
Compound 4e: Yield: 44%; salmon solid; mp 110.6–111.3 °C. 1H
NMR (300 MHz, CDCl3): δ = 7.71 (d, J = 8.6 Hz, 2 H, H-2′,6′), 7.55
(d, J = 8.6 Hz, 2 H, H-3′,5′), 7.37–7.18 (m, 5 H, H-2′′,6′′, H-3′′,5′′,
H-4′′), 6.46 (d, J = 15.8 Hz, 1 H, H-β), 6.23 (dd, J = 15.8, 8.2 Hz,
1 H, H-α), 4.38–4.24 (m, 1 H, H-5), 3.94–3.82 (m, 1 H, H-5),
3.38–3.16 (m, 2 H, H-3, H-4), 2.92–2.79 (m, 1 H, H-3). 13C NMR
(75 MHz, CDCl3): δ = 171.8 (C-2), 137.0 (C-1′′), 133.2 (C-4′),
132.0 (C-α), 131.7 (C-3′,5′), 130.2 (C-β), 129.1 (C-2′,6′), 128.6 (C-
3′′,5′′), 127.4 (C-4′′), 126.1 (C-2′′,6′′), 125.1 (C-1′), 67.4 (C-5),
41.8 (C-3), 41.4 (C-4). HRMS (ESI+): m/z [C18H16BrN + H]+ calcd
1,5-diaryl-3-(nitromethyl)-5-pent-4-en-1-ones 3. There
was no racemization of the asymmetric carbon, and the
trans-geometry of the double bond was retained. This
methodology is being applied in our laboratory to the syn-
thesis of Δ1-pyrroline boranyl complexes.
Acknowledgment
Thanks are due to the University of Aveiro and the Portuguese
Fundação para a Ciência e a Tecnologia (FCT) for funding the Organic
Chemistry Research Unit (project PEst- C/QUI/UI0062/2013), the
CICECO Associate Laboratory (PEst-C/CTM/LA0011/2013) and the
Portuguese National NMR Network (RNRMN). D.I.S.P.R. and S.G. also
thank the FCT for a doctoral grant (SFRH/BD/62696/2009) and a post-
doctoral grant (SFRH/BPD/70702/2010), respectively.
Supporting Information
Supporting information for this article is available online at
S
u
p
p
ortiInfogrmoaitn
S
u
p
p
ortioInfgrmoaitn
References and Notes
(1) Current address: Medicinal Chemistry Section, Experimental
Therapeutics Programme, CNIO (Spanish National Cancer
Research Centre), Madrid, Spain.
(2) Huang, P.-Q. Asymmetric Synthesis of Five Membered Ring Het-
erocycles, In Asymmetric Synthesis of Nitrogen Heterocycles;
Royer, J., Ed.; Wiley-VCH: Weinheim, 2009.
for
C18H17BrN: 326.0539; found: 326.0537. HPLC (i-PrOH–
hexane, 10:90; flow rate 0.7 mL/min; λ = 254 nm): tr = 13.07
[(R)-4e] min (ee = 99%).
(3) Pinder, A. R. Nat. Prod. Rep. 1992, 9, 491.
(17) Crystal data for 4d: C18H16ClN; M = 281.77; orthorhombic; space
group P212121; Z = 4; a = 5.6675(7) Å, b = 7.8846(12) Å, c =
32.643(3) Å, α = β = γ = 90.00°; V = 1458.7(3) Å3; colorless
crystal with crystal size of 0.10 × 0.08 × 0.04 mm was used. Of a
total of 2942 reflections collected, 2022 were independent (Rint
= 0.0968). Final R1 = 0.0614 [I > 2σ(I)] and wR2 = 0.1591 (all
data). Crystal data for 4e: C18H16FN; M = 265.32; orthorhombic;
space group P212121; Z = 4; a = 5.6544(6) Å, b = 7.9709(8) Å, c =
(4) Asghari, S.; Qandalee, M. Synth. Commun. 2010, 40, 2172.
(5) Cardona, F.; Rocha, J.; Silva, A. M. S.; Guieu, S. Dyes Pigm. 2014,
111, 16.
(6) Marrec, O.; Christophe, C.; Billard, T.; Langlois, B.; Vors, J.-P.;
Pazenok, S. Adv. Synth. Catal. 2010, 352, 2825.
(7) Shvekhgeimer, M. G. A. Chem. Heterocycl. Compd. 2003, 39, 405.
© Georg Thieme Verlag Stuttgart · New York — Synlett 2015, 26, 846–850